Société Cerevel Therapeutics Holdings, Inc.
Actions
CERE
US15678U1280
Recherche biotechnologique et médicale
Temps réel estimé
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
42,44 USD | -0,07 % | +0,82 % | +0,11 % |
Métier
Nombre d'employés: 334
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Ronald Renaud
CEO | Chief Executive Officer | 55 | 12/06/23 |
Director of Finance/CFO | 43 | 15/05/23 | |
N. Coles
CHM | Chairman | 63 | 01/12/18 |
Raymond Sanchez
CTO | Chief Tech/Sci/R&D Officer | 63 | 01/01/19 |
John Renger
CTO | Chief Tech/Sci/R&D Officer | 55 | 01/05/19 |
53 | - | ||
Matthew Calistri
IRC | Investor Relations Contact | - | - |
Scott Akamine
LAW | General Counsel | 40 | 24/05/21 |
Mark Bodenrader
AUD | Comptroller/Controller/Auditor | 51 | 01/09/19 |
Paul Burgess
PRN | Corporate Officer/Principal | 50 | 20/06/23 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Director/Board Member | 63 | 01/06/19 | |
Douglas Giordano
BRD | Director/Board Member | 61 | 01/09/18 |
Ruth McKernan
BRD | Director/Board Member | 66 | 04/12/20 |
Deval Patrick
BRD | Director/Board Member | 67 | 20/01/21 |
Marijn Dekkers
BRD | Director/Board Member | 65 | 01/09/18 |
Norbert Riedel
BRD | Director/Board Member | 66 | 01/12/18 |
N. Coles
CHM | Chairman | 63 | 01/12/18 |
Ronald Renaud
CEO | Chief Executive Officer | 55 | 12/06/23 |
Director/Board Member | 51 | 01/09/18 | |
Adam Koppel
BRD | Director/Board Member | 54 | 01/09/18 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 181 576 482 | 76 702 134 ( 42,24 %) | 0 | 42,24 % |
Coordonnées société
Cerevel Therapeutics Holdings, Inc.
222 Jacobs Street Suite 200
02141, Cambridge
+844 304 2048
http://www.cerevel.comSecteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
+0,11 % | 7,71 Md | |
-2,44 % | 103 Md | |
+1,93 % | 95,28 Md | |
+1,66 % | 22,15 Md | |
-15,42 % | 21,02 Md | |
-8,58 % | 18,15 Md | |
-41,01 % | 16,73 Md | |
-13,12 % | 16,05 Md | |
+4,14 % | 13,68 Md | |
+35,44 % | 12,17 Md |
- Bourse
- Actions
- Action CERE
- Société Cerevel Therapeutics Holdings, Inc.